Healthcare Industry Today
sign up now for free trial
FORMATS: RSS | EMAIL | MOBILE

Latest Advexin News

  • Introgen gets second notice from Nasdaq, says it will fight removal from exchange 7 Oct 2008 00:30 GMT
    ... , the Austin drug company working to bring a head and neck cancer treatment to the market, has received its second ... market its head and neck cancer drug Advexin. Introgen has spent more than a decade ...

  • Introgen Receives Notification from Nasdaq 4 Oct 2008 15:19 GMT
    ... commercialization of targeted molecular therapies for the treatment of cancer and other diseases. Introgen is ... to the FDA requesting marketing approval for ADVEXIN p53 therapy to treat recurrent, refractory head ... limited experience in the development of gene-based drugs in general, dependence upon proprietary technology and ...


1 - 2 / 2

NOT SATISFIED WITH THIS ADVEXIN NEWS SECTION? MAKE YOUR OWN WITH THE INBOX ROBOT OR TRY OUR OTHER MEDIA MONITORING SERVICES.
These stories are not published by IPD Group, Inc. and these links will take you to other websites. Some of these websites require their own registration to read their stories.
<<< Please read the disclaimer for more details.>>>
 
Get a FREE daily news alert by email. Subscribe here.
Your email:
customized media monitoring
REACH 1,000,000 READERS A MONTH! ADVERTISE HERE
 

Take This Poll

Is the planned bailout of the U.S. financial system really necessary? (Sep. 26, 2008)



 

EIN News Copyright © 2005-2008 IPD Group, Inc. All Rights Reseved. | User Agreement | Privacy Policy | Contact